Innoviva Inc

Small-Cap Stocks Pharmaceutical Stocks Healthcare Stocks

$21.12

+0.08 (+0.38%)

As of Sep 22, 1:45 PM ET ·

Analyst Consensus

Strong Buy

Analysts

Moderate

Coverage

Buy 9 82%

Hold 1 9%

Sell 1 9%

Price Target

Analyst Price Target +85.4% upside

Low Target $23.99

Average Target $39.16

High Target $41.33

Current Price $21.12

Current
$21.12

Target
$39.16

$23.99 $39.16 avg $41.33

Scenario Analysis

Bear Case

$23.99

13.6%

Low target

Base Case

$39.16

+85.4%

Avg target

Bull Case

$41.33

+95.7%

High target

Risk/Reward

7.0x

Highly favorable

Price in Context

52-Week High

$25.15

-16.0% from high

52-Week Low

$16.52

+27.8% from low

Target vs 52W High

$39.16

+55.7% vs high

Peer Consensus — Pharmaceuticals

Stock	Consensus	Analysts	Buy %	Target	Upside
LLY Eli Lilly and Co.	Strong Buy	38	79%	$1,330.33	+13.7%
RDY Dr. Reddy's Laboratories	Strong Sell	45	31%	—	+0.0%
JNJ Johnson & Johnson	Buy	31	71%	$299.55	+11.3%
MRK Merck & Co. Inc.	Buy	36	72%	$159.27	+5.5%
PFE Pfizer Inc.	Hold	36	39%	$33.90	+21.4%
BMY Bristol-Myers Squibb Co	Hold	35	43%	$174.50	+180.3%
RPRX Royalty Pharma Plc- Cl A	Strong Buy	16	88%	$36.26	-38.0%
ZTS Zoetis Inc	Hold	24	50%	$209.87	+188.0%